keyword
https://read.qxmd.com/read/38641742/risk-based-lung-cancer-screening-performance-in-a-universal-healthcare-setting
#21
JOURNAL ARTICLE
Martin C Tammemägi, Gail E Darling, Heidi Schmidt, Meghan J Walker, Deanna Langer, Yvonne W Leung, Kathy Nguyen, Beth Miller, Diego Llovet, William K Evans, Daniel N Buchanan, Gabriela Espino-Hernandez, Usman Aslam, Amanda Sheppard, Aisha Lofters, Micheal McInnis, Julian Dobranowski, Steven Habbous, Christian Finley, Marianne Luettschwager, Erin Cameron, Caroline Bravo, Anna Banaszewska, Katherin Creighton-Taylor, Brenda Fernandes, Julia Gao, Alex Lee, Van Lee, Bogdan Pylypenko, Monica Yu, Erin Svara, Shivali Kaushal, Lynda MacNiven, Caitlin McGarry, Lauren Della Mora, Liz Koen, Jessica Moffatt, Michelle Rey, Marta Yurcan, Laurie Bourne, Gillian Bromfield, Melissa Coulson, Rebecca Truscott, Linda Rabeneck
Globally, lung cancer is the leading cause of cancer death. Previous trials demonstrated that low-dose computed tomography lung cancer screening of high-risk individuals can reduce lung cancer mortality by 20% or more. Lung cancer screening has been approved by major guidelines in the United States, and over 4,000 sites offer screening. Adoption of lung screening outside the United States has, until recently, been slow. Between June 2017 and May 2019, the Ontario Lung Cancer Screening Pilot successfully recruited 7,768 individuals at high risk identified by using the PLCOm2012noRace lung cancer risk prediction model...
April 2024: Nature Medicine
https://read.qxmd.com/read/38641182/unveiling-clinical-applications-of-bacterial-extracellular-vesicles-as-natural-nanomaterials-in-disease-diagnosis-and-therapeutics
#22
REVIEW
Chun Liu, Negar Yazdani, Corey S Moran, Carlos Salomon, Chaminda Jayampath Seneviratne, Sašo Ivanovski, Pingping Han
Bacterial extracellular vesicles (BEVs) are naturally occurring bioactive membrane-bound nanoparticles released by both gram-negative and positive bacterial species, exhibiting a multifaceted role in mediating host-microbe interactions across various physiological conditions. Increasing evidence supports BEVs as essential mediators of intercellular exchange, influencing bacterial pathogenicity, disease mechanisms, and modulating the host immune response. However, the extent to which these BEV-mediated actions can be leveraged to predict disease onset, guide treatment strategies, and determine clinical outcomes remains uncertain, particularly in terms of their clinical translation potentials...
April 17, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38641151/biological-evaluation-of-sulfonate-and-sulfate-analogues-of-lithocholic-acid-a-bioisosterism-guided-approach-towards-the-discovery-of-potential-sialyltransferase-inhibitors-for-antimetastatic-study
#23
JOURNAL ARTICLE
Ser John Lynon P Perez, Chia-Ling Chen, Tzu-Ting Chang, Wen-Shan Li
The naturally occurring bile acid lithocholic acid (LCA) has been a crucial core structure for many non-sugar-containing sialyltranferase (ST) inhibitors documented in literature. With the aim of elucidating the impact of the terminal carboxyl acid substituent of LCA on its ST inhibition, in this present study, we report the (bio)isosteric replacement-based design and synthesis of sulfonate and sulfate analogues of LCA. Among these compounds, the sulfate analogue SPP-002 was found to selectively inhibit N-glycan sialylation by at least an order of magnitude, indicating a substantial improvement in both potency and selectivity when compared to the unmodified parent bile acid...
April 17, 2024: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/38640855/arenobufagin-enhances-t-cell-anti-tumor-immunity-in-colorectal-cancer-by-modulating-hsp90%C3%AE-accessibility
#24
JOURNAL ARTICLE
Zhihao Shang, Yiping Fan, Songyang Xi, Shang Zhang, Weixing Shen, Lihuiping Tao, Changliang Xu, Jiani Tan, Minmin Fan, Hongyue Ma, Yueyang Lai, Dongdong Sun, Haibo Cheng
BACKGROUND: Colorectal cancer (CRC) is a significant public health issue, ranking as one of the predominant cancer types globally in terms of incidence. Intriguingly, Arenobufagin (Are), a compound extracted from toad venom, has demonstrated the potential to inhibit tumor growth effectively. PURPOSE: This study aimed to explore Are's molecular targets and unravel its antitumor mechanism in CRC. Specifically, we were interested in its impact on immune checkpoint modulation and correlations with HSP90β-STAT3-PD-L1 axis activity...
February 28, 2024: Phytomedicine
https://read.qxmd.com/read/38640836/parp-inhibitors-suppress-tumours-via-centrosome-error-induced-senescence-independent-of-dna-damage-response
#25
JOURNAL ARTICLE
Wei Yue, Xinyu Li, Xiaolu Zhan, Lei Wang, Jihong Ma, Meiyu Bi, Qilong Wang, Xiaoyang Gu, Bingteng Xie, Tong Liu, Hongyan Guo, Xin Zhu, Chen Song, Jie Qiao, Mo Li
BACKGROUND: Poly(ADP-ribose) polymerase (PARP) inhibitors have emerged as promising chemotherapeutic drugs primarily against BRCA1/2-associated tumours, known as synthetic lethality. However, recent clinical trials reported patients' survival benefits from PARP inhibitor treatments, irrelevant to homologous recombination deficiency. Therefore, revealing the therapeutic mechanism of PARP inhibitors beyond DNA damage repair is urgently needed, which can facilitate precision medicine. METHODS: A CRISPR-based knock-in technology was used to establish stable BRCA1 mutant cancer cells...
April 18, 2024: EBioMedicine
https://read.qxmd.com/read/38639281/biosynthesis-and-anticancer-activity-of-genistein-glycoside-derivatives
#26
JOURNAL ARTICLE
Xing Zheng, Jun Zhang, Shun Liu, Yingzi Yu, Qingying Peng, Yaling Peng, Xu Yao, Xingxing Peng, Jing Zhou
As a beneficial natural flavonoid, genistein has demonstrated a wide range of biological functions via regulating a number of targets and signaling pathways, such as anti-cancer, antioxidant, antibacterial, antiinflammatory, antifungal, antiviral, iron chelation, anti-obesity, anti-diabetes, and anti-hypertension. PubMed/Medline and Web of Science were searched using appropriate keywords until the end of December 2023. Despite its many potential benefits, genistein's clinical application is limited by low hydrophilicity, poor solubility, and suboptimal bioavailability due to its structure...
April 18, 2024: Anti-cancer Agents in Medicinal Chemistry
https://read.qxmd.com/read/38639278/polyphenols-modulate-the-mirnas-expression-that-involved-in-glioblastoma
#27
JOURNAL ARTICLE
Maede Rezaie, Mohammad Nasehi, Mohammad Shimia, Mohamad Ebrahimnezhad, Bahman Yousefi, Maryam Majidinia
Glioblastoma multiforme (GBM), a solid tumor that develops from astrocytes, is one of the most aggressive types of brain cancer. While there have been improvements in the efficacy of treating GBM, many problems remain, especially with traditional therapy methods. Therefore, recent studies have extensively focused on developing novel therapeutic agents for combating glioblastoma. Natural polyphenols have been studied for their potential as chemopreventive and chemotherapeutic agents due to their wide range of positive qualities, including antioxidant, antiinflammatory, cytotoxic, antineoplastic, and immunomodulatory activities...
April 18, 2024: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/38637802/the-interaction-of-platelet-related-factors-with-tumor-cells-promotes-tumor-metastasis
#28
REVIEW
Jie Xue, Jianzhao Deng, Hongwei Qin, Songxia Yan, Zhen Zhao, Lifeng Qin, Jiao Liu, Haiyan Wang
Platelets not only participate in thrombosis and hemostasis but also interact with tumor cells and protect them from mechanical damage caused by hemodynamic shear stress and natural killer cell lysis, thereby promoting their colonization and metastasis to distant organs. Platelets can affect the tumor microenvironment via interactions between platelet-related factors and tumor cells. Metastasis is a key event in cancer-related death and is associated with platelet-related factors in lung, breast, and colorectal cancers...
April 18, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38637796/sparassis-latifolia-and-exercise-training-as-complementary-medicine-mitigated-the-5-fluorouracil-potent-side-effects-in-mice-with-colorectal-cancer-bioinformatics-approaches-novel-monitoring-pathological-metrics-screening-signatures-and-innovative%C3%A2-management
#29
JOURNAL ARTICLE
Navid Abedpoor, Farzaneh Taghian, Khosro Jalali Dehkordi, Kamran Safavi
BACKGROUND: Prompt identification and assessment of the disease are essential for reducing the death rate associated with colorectal cancer (COL). Identifying specific causal or sensitive components, such as coding RNA (cRNA) and non-coding RNAs (ncRNAs), may greatly aid in the early detection of colorectal cancer. METHODS: For this purpose, we gave natural chemicals obtained from Sparassis latifolia (SLPs) either alone or in conjunction with chemotherapy (5-Fluorouracil to a mouse colorectal tumor model induced by AOM-DSS...
April 18, 2024: Cancer Cell International
https://read.qxmd.com/read/38637635/development-and-validation-of-a-new-algorithm-for-improved-cardiovascular-risk-prediction
#30
JOURNAL ARTICLE
Julia Hippisley-Cox, Carol A C Coupland, Mona Bafadhel, Richard E K Russell, Aziz Sheikh, Peter Brindle, Keith M Channon
QRISK algorithms use data from millions of people to help clinicians identify individuals at high risk of cardiovascular disease (CVD). Here, we derive and externally validate a new algorithm, which we have named QR4, that incorporates novel risk factors to estimate 10-year CVD risk separately for men and women. Health data from 9.98 million and 6.79 million adults from the United Kingdom were used for derivation and validation of the algorithm, respectively. Cause-specific Cox models were used to develop models to predict CVD risk, and the performance of QR4 was compared with version 3 of QRISK, Systematic Coronary Risk Evaluation 2 (SCORE2) and atherosclerotic cardiovascular disease (ASCVD) risk scores...
April 18, 2024: Nature Medicine
https://read.qxmd.com/read/38637634/targeting-kras-in-cancer
#31
REVIEW
Anupriya Singhal, Bob T Li, Eileen M O'Reilly
RAS family variants-most of which involve KRAS-are the most commonly occurring hotspot mutations in human cancers and are associated with a poor prognosis. For almost four decades, KRAS has been considered undruggable, in part due to its structure, which lacks small-molecule binding sites. But recent developments in bioengineering, organic chemistry and related fields have provided the infrastructure to make direct KRAS targeting possible. The first successes occurred with allele-specific targeting of KRAS p...
April 2024: Nature Medicine
https://read.qxmd.com/read/38637590/polycystic-ovary-syndrome
#32
REVIEW
Elisabet Stener-Victorin, Helena Teede, Robert J Norman, Richard Legro, Mark O Goodarzi, Anuja Dokras, Joop Laven, Kathleen Hoeger, Terhi T Piltonen
Despite affecting ~11-13% of women globally, polycystic ovary syndrome (PCOS) is a substantially understudied condition. PCOS, possibly extending to men's health, imposes a considerable health and economic burden worldwide. Diagnosis in adults follows the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, requiring two out of three criteria - clinical or biochemical hyperandrogenism, ovulatory dysfunction, and/or specific ovarian morphological characteristics or elevated anti-Müllerian hormone...
April 18, 2024: Nature Reviews. Disease Primers
https://read.qxmd.com/read/38637560/somatic-mutations-of-esophageal-adenocarcinoma-a-comparison-between-black-and-white-patients
#33
JOURNAL ARTICLE
Hyeyeun Lim, Marie-Claude Gingras, Jing Zhao, Jinyoung Byun, Patricia D Castro, Spiridon Tsavachidis, Jianhong Hu, Harshavardhan Doddapaneni, Yi Han, Donna M Muzny, Richard A Gibbs, Christopher I Amos, Aaron P Thrift
Esophageal adenocarcinoma is the most common histological subtype of esophageal cancer in Western countries and shows poor prognosis with rapid growth. EAC is characterized by a strong male predominance and racial disparity. EAC is up to fivefold more common among Whites than Blacks, yet Black patients with EAC have poorer survival rates. The racial disparity remains largely unknown, and there is limited knowledge of mutations in EAC regarding racial disparities. We used whole-exome sequencing to show somatic mutation profiles derived from tumor samples from 18 EAC male patients...
April 18, 2024: Scientific Reports
https://read.qxmd.com/read/38636811/nisin-variants-what-makes-them-different-and-unique
#34
REVIEW
Weslei da Silva Oliveira, César Roberto Viana Teixeira, Hilário Cuquetto Mantovani, Silvio Santana Dolabella, Sona Jain, Ana Andréa Teixeira Barbosa
Nisin A is a lantibiotic bacteriocin typically produced by strains of Lactococcus lactis. This bacteriocin has been approved as a natural food preservative since the late 1980s and shows antimicrobial activity against a range of food-borne spoilage and pathogenic microorganisms. The therapeutic potential of nisin A has also been explored increasingly both in human and veterinary medicine. Nisin has been shown to be effective in treating bovine mastitis, dental caries, cancer, and skin infections. Recently, it was demonstrated that nisin has an affinity for the same receptor used by SARS-CoV-2 to enter human cells and was proposed as a blocker of the viral infection...
April 16, 2024: Peptides
https://read.qxmd.com/read/38636332/sa-ttca-an-svm-based-approach-for-tumor-t-cell-antigen-classification-using-features-extracted-from-biological-sequencing-and-natural-language-processing
#35
JOURNAL ARTICLE
Thi-Oanh Tran, Nguyen Quoc Khanh Le
Accurately predicting tumor T-cell antigen (TTCA) sequences is a crucial task in the development of cancer vaccines and immunotherapies. TTCAs derived from tumor cells, are presented to immune cells (T cells) through major histocompatibility complex (MHC), via the recognition of specific portions of their structure known as epitopes. More specifically, MHC class I introduces TTCAs to T-cell receptors (TCR) which are located on the surface of CD8+ T cells. However, TTCA sequences are varied and lead to struggles in vaccine design...
April 4, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38635551/enhanced-cytotoxic-activity-of-natural-killer-cells-from-increased-calcium-influx-induced-by-electrical-stimulation
#36
JOURNAL ARTICLE
Minseon Lee, Soonjo Kwon
Natural killer (NK) cells play a crucial role in immunosurveillance independent of antigen presentation, which is regulated by signal balance via activating and inhibitory receptors. The anti-tumor activity of NK cells is largely dependent on signaling from target recognition to cytolytic degranulation; however, the underlying mechanism remains unclear, and NK cell cytotoxicity is readily impaired by tumor cells. Understanding the activation mechanism is necessary to overcome the immune evasion mechanism, which remains an obstacle in immunotherapy...
2024: PloS One
https://read.qxmd.com/read/38635542/from-code-to-care-clinician-and-researcher-perspectives-on-an-optimal-therapeutic-web-portal-for-acute-myeloid-leukemia
#37
JOURNAL ARTICLE
Terese Knoppers, Cassandra E Haley, Sarah Bouhouita-Guermech, Julie Hagan, Jacqueline Bradbury-Jost, Samuel Alarie, Marie Cosquer, Ma'n H Zawati
BACKGROUND: Acute myeloid leukemia (AML), a rapidly progressing cancer of the blood and bone marrow, is the most common and fatal type of adult leukemia. Therapeutic web portals have great potential to facilitate AML research advances and improve health outcomes by increasing the availability of data, the speed and reach of new knowledge, and the communication between researchers and clinicians in the field. However, there is a need for stakeholder research regarding their optimal features, utility, and implementation...
2024: PloS One
https://read.qxmd.com/read/38634704/thiostrepton-suppresses-triple-negative-breast-cancer-through-downregulating-c-flip-smad2-3-signaling-pathway
#38
JOURNAL ARTICLE
Wen-Die Wang, Chao-Yang Zeng, Yue Shang, Jun Ni, Gao-Jie Li, Li-Ping Li, Shuo-Han Xi, Shu-Zhen Chen
Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis of breast cancer. Thiostrepton exerts anti-tumor activities against several cancers including TNBC. Herein we discussed the new molecular mechanisms of thiostrepton in TNBC. Thiostrepton inhibited MDA-MB-231 cell viability, accompanied by a decrease of c-FLIP and p-SMAD2/3. c-FLIP overexpression reduced the sensitivity of MDA-MB-231 cells to thiostrepton, while SMAD2/3 knockdown increased the sensitivity of MDA-MB-231 cells to thiostrepton...
April 18, 2024: Journal of Asian Natural Products Research
https://read.qxmd.com/read/38634408/a-mechanistic-review-on-growing-multiple-therapeutic-applications-of-lutein-and-its-global-market-research
#39
REVIEW
Ashish Sunil Akkewar, Km Abha Mishra, Mahesh Gopichand Kamble, Sanjay Kumar, Juhi Dey, Kalyan Kumar Sethi
Lutein is a naturally occurring carotenoid synthesized by plants and algae that has a beneficial effect on several biological processes and associated ailments. Its immediate application is in ophthalmology, where it significantly lowers the incidences of age-related macular degeneration (AMD). It also has anti-inflammatory action, treatment of diabetic retinopathy, and cataracts, and enhancement of visual contrast. To critically assess lutein biosynthesis, therapeutic applicability, and market research literature...
April 18, 2024: Phytotherapy Research: PTR
https://read.qxmd.com/read/38634147/metabolome-microbiome-insights-into-therapeutic-impact-of-8-o-acetylharpagide-against-breast-cancer-in-a-murine-model
#40
JOURNAL ARTICLE
Jiahui Qian, Xinyu Zhao, Siyuan Yuan, Sijia Su, Chang Chen, Junfeng Gao, Xu Tang, Siye Men, Binyu Wen
Iridoid glycosides extract, which is the main active extract of Ajuga decumbens Thunb, has been proved to have anti-breast cancer activity in previous studies. However, it is still unknown whether 8-O-acetylharpagide, a main active compound in the extract, has anti-breast cancer activity. In this study, 4 T1 breast cancer mice model was first successfully established. Then the anti-breast cancer effect of 8-O-acetylharpagide was systematically investigated. Feces were collected for metabolomics and 16S rRNA analysis to assess the potential mechanism...
April 17, 2024: Biomedical Chromatography: BMC
keyword
keyword
17051
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.